NCT01546818View on ClinicalTrials.gov

Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

September 30, 2013

Conditions
HIV Infections
Interventions
BIOLOGICAL

SAV001-H

A whole-killed HIV

Trial Locations (1)

90069

Anthony Mills, MD Internal Medicine, Los Angeles

Sponsors

Lead Sponsor

Sumagen
All Listed Sponsors
lead

Sumagen

INDUSTRY

NCT01546818 - Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients | Biotech Hunter | Biotech Hunter